Navigation Links
Bioenergy D-Ribose Achieves Highest Safety Standard
Date:11/20/2008

MINNEAPOLIS, Nov. 20 /PRNewswire/ -- Integrative life science company Bioenergy, Inc. has achieved GRAS status (generally recognized as safe) from the U.S. Food and Drug Administration (FDA) for its core energy nutrient D-ribose, a naturally occurring monosaccharide the body uses to stimulate the synthesis of adenosine triphosphate (ATP) -- an essential energy compound.

"The FDA's written response that it has reviewed the submitted safety evidence and has no questions about the GRAS determination for D-ribose is the government's highest recognition of a food ingredient for safety and purity," said Raj Khankari, Ph.D., CEO of Bioenergy, Inc. The company has held "self-affirmed" GRAS status for years. "Today, we are gratified that the FDA has officially validated our assessment."

"The FDA's 'no questions letter' signals to the major food and beverage manufacturers that we have invested all the resources possible to guarantee the quality and safety of our D-ribose products for the benefit of customers and consumers."

Bioenergy has amassed a large body of scientific literature regarding uses of ribose for people across all age and health categories. The company has more than 40,000 customers for its proprietary Corvalen products alone, and millions worldwide use Bioenergy ribose in other products. It is commonly found in functional foods like energy bars (Detour, FastFuel, Marathon) and beverages (SoBe Adrenaline Rush, Vitamin Water, Snapple Antioxidant Water). Currently, Bioenergy D-ribose is included as an ingredient in approximately 100 products.

In larger quantities as a Medical Food, D-Ribose also has been shown to assist patients with compromised heart function and is also widely used by patients with Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FMS).

Bioenergy, Inc. (http://www.bioenergy.com) is a privately held, Minneapolis-based life sciences company whose core technology lies in the development and commercialization of products based on the physiological benefits of D-ribose for health and wellness. In addition to a pharmaceutical subsidiary, Bioenergy has two other companies. Bioenergy Life Science, Inc. manufactures and sells D-ribose as an ingredient to nutraceutical firms for beverages and foods; as a medical food through doctors and clinics; and as a dietary supplement for energy recovery (reduces fatigue, muscle pain, soreness and stiffness following exercise). Viacell, LLC is developing technology related to the enhancement of blood components.


'/>"/>
SOURCE Bioenergy, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Media Advisory - Atlantica BioEnergy Task Force Leaders Roundtable
2. Universal Bioenergy, Inc. Seeks Algae Feedstock Companies for Acquisition, Alliance, and Joint Venture Opportunities for Biodiesel Production
3. BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board
4. BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc.
5. Fulcrum BioEnergy Announces Plans to Build One of the First Commercial-Scale Ethanol Plants Using Municipal Solid Waste as Feedstock
6. Raj Khankari Named Bioenergy, Inc., CEO
7. Atlantica BioEnergy Task Force Unveiled
8. Bioenergy Life Science and Integrative Therapeutics, Inc. Form Exclusive Co-Marketing Alliance
9. BioEnergy International Facility Opens in Bay State
10. Biomaxx Systems Inc. Renews Membership With Bioenergy Australia
11. D-Ribose Helps Energy-Starved Hearts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... , ... October 10, 2017 , ... ... and business process optimization firm for the life sciences and healthcare industries, announces ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud ...
(Date:10/9/2017)... ... October 09, 2017 , ... At its national board ... Stubbs, a professor in Harvard University’s Departments of Physics and Astronomy, has been selected ... member of the winning team for the 2015 Breakthrough Prize in Fundamental physics for ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... genomic technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first ... accompanying cloud-based bioinformatics software to perform Hi-C metagenome deconvolution using their own ...
(Date:10/5/2017)... ... October 05, 2017 , ... LabRoots , the leading provider of ... world, is giving back to cancer research with a month-long promotion supporting the advancement ... October 31, shoppers can use promo code PinkRibbon to get 10 percent off their ...
Breaking Biology Technology:
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities and ... and behavioral), by technology (fingerprint, AFIS, iris recognition, facial ... and others), by end use industry (government and law ... financial and banking, and others), and by region ( ... , Asia Pacific , and the ...
(Date:3/27/2017)... March 27, 2017  Catholic Health Services (CHS) ... Systems Society (HIMSS) Analytics for achieving Stage 6 ... sm . In addition, CHS previously earned a ... using an electronic medical record (EMR). ... level of EMR usage in an outpatient setting.  ...
Breaking Biology News(10 mins):